Anxiety and Depression in Multiple Sclerosis (MS): Antecedents, Consequences, and Differential Impact on Well-being and Quality of Life
Open accessAbstract
Background Individuals with multiple sclerosis (MS) are often plagued by the unpredictability of their disease and have to contend with uncertainty in their life and significant life changes. This can lead to high levels of stress, perceived lack of control, helplessness, and anxiety. Despite these circumstances, anxiety disorders are often overshadowed by depression, which can result in its presence being overlooked and undertreated by many medical professionals. Methods One hundred and eighty three individuals with MS completed a comprehensive online survey assessing depression and anxiety and the demographic and disease risk factors of such, including social support and substance use. Participants also completed measures of MS symptomatology, disease management, psychological well-being, and quality of life to determine the impact of depression and anxiety on outcomes associated with MS. Results Findings suggest that both depression and anxiety are prevalent in MS and related to many outcomes. However, based on comparisons of the associations and group comparisons, with a few exceptions, anxiety proved to more impactful than depression when examining these outcomes. When evaluating the risk factors/contributors of anxiety and depression, social support was a consistent predictor. Younger age and shorter disease duration were also associated with anxiety, while lower education and substance use were predictors of depression. Conclusion Findings suggest that attention to anxiety be given as much as depression as it plays a large role in individuals' perceived health and well-being, which subsequently impacts the severity of symptoms and overall quality of life. Early identification of anxiety and potential substance use and increased social support also appear to be crucial for mitigating the impact of depression and anxiety.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Individuals with MS are at heightened risk for mental health disorders, such as depression and various forms of anxiety, including death anxiety.
“Furthermore, individuals with MS are at a heightened risk for mental health disorders, such as depression and various forms of anxiety, including death anxiety (DA), which is characterized by intense feelings of terror, fear, or excessive worry regarding the process of dying, severing connection with the world, or uncertainties about what happens after death.”
From Comparing the Effects of Mindfulness-based Cognitive Therapy and Acceptance and Commitment Therapy on Quality of Life and Death Anxiety in Women With Multiple Sclerosis (2025) · cites this paper as [7]
The Introduction sections “Depression in MS” and “Anxiety in MS” report substantial prevalence of both conditions among people with MS. The cited paper does not address death anxiety specifically or give the definition of it in the citing sentence; searches for death anxiety and fear of dying found no supporting passage. Page numbers were not available in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measuredPsychological disorders contribute to declined quality of life in MS patients.
“These psychological disorders contribute to declined quality of life (QOL), which encompasses an individual's well-being, including physical, psychological, social, and environmental factors.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234 · see citing works
A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807 · see citing works
The satisfaction with life scale
Diener, E., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985) · Journal of Personality Assessment · doi:10.1207/s15327752jpa4901_13 · Cited by 31,768 · see citing works
Assessing coping strategies: A theoretically based approach.
Carver, C. S., Scheier, M. F., & Weintraub, J. K. (1989) · Journal of Personality and Social Psychology · doi:10.1037//0022-3514.56.2.267 · Cited by 11,679 · see citing works
New well-being measures: Short scales to assess flourishing and positive and negative feelings
Diener, E., Wirtz, D., Tov, W., Kim-Prieto, C., Choi, D.-W., Oishi, S., & Biswas-Diener, R. (2010) · Social Indicators Research · doi:10.1007/s11205-009-9493-y · Cited by 4,980 · see citing works
Measuring the Functional Impact of Fatigue: Initial Validation of the Fatigue Impact Scale
Fisk, J. D., Ritvo, P. G., Ross, L., Haase, D. A., Marrie, T. J., & Schlech, W. F. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.supplement_1.s79 · Cited by 1,546 · see citing works
Confavreux, C. (2003) · Brain · doi:10.1093/brain/awg081 · Cited by 997 · see citing works
Depression in multiple sclerosis: a review
Siegert, R. J. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054635 · Cited by 718 · see citing works
Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis
Boeschoten, R. E., Braamse, A. M. J., Beekman, A. T. F., Cuijpers, P., van Oppen, P., Dekker, J., & Uitdehaag, B. M. J. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.11.067 · Cited by 713 · see citing works
Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1862 · Cited by 555 · see citing works
Scott, K. M., Bruffaerts, R., Tsang, A., Ormel, J., Alonso, J., Angermeyer, M. C., Benjet, C., Bromet, E., de Girolamo, G., de Graaf, R., et al. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.01.015 · Cited by 529 · see citing works
Sex and gender issues in multiple sclerosis
Harbo, H. F., Gold, R., & Tintoré, M. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613488434 · Cited by 529 · see citing works
Anxiety disorders and their clinical correlates in multiple sclerosis patients
Korostil, M., & Feinstein, A. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071161 · Cited by 424 · see citing works
Comorbid Anxiety and Depression: Clinical and Conceptual Consideration and Transdiagnostic Treatment
Choi, K. W., Kim, Y., & Jeon, H. J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9705-0_14 · Cited by 318 · see citing works
Bruce, J. M., Hancock, L. M., Arnett, P., & Lynch, S. (2010) · Journal of behavioral medicine · doi:10.1007/s10865-010-9247-y · Cited by 297 · see citing works
Brown, L. F., Kroenke, K., Theobald, D. E., Wu, J., & Tu, W. (2010) · Psycho-Oncology · doi:10.1002/pon.1627 · Cited by 295 · see citing works
Depression and anxiety amongst multiple sclerosis patients
Beiske, A. G., Svensson, E., Sandanger, I., Czujko, B., Pedersen, E. D., Aarseth, J. H., & Myhr, K. M. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.02041.x · Cited by 257 · see citing works
Current diagnosis and treatment of anxiety disorders.
Bystritsky, A., Khalsa, S. S., Cameron, M., & Schiffman, J. E. (2013) · Europe PMC (PubMed Central) · Cited by 251 · see citing works
(2006) · UCL Discovery (University College London) · Cited by 224 · see citing works
STRUCTURAL BRAIN CORRELATES OF EMOTIONAL DISORDER IN MULTIPLE SCLEROSIS
Rabins, P. V., Brooks, B. R., O'Donnell, P. V., Pearlson, G. D., Moberg, P. J., Jubelt, B., Coyle, P. K., Dalos, N. P., & Folstein, M. F. (1986) · Brain · doi:10.1093/brain/109.4.585 · Cited by 195 · see citing works
Schiffer, R. B. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050210065016 · Cited by 187 · see citing works
D'Alisa, S., Miscio, G., Baudo, S., Simone, A., Tesio, L., & Mauro, A. (2006) · Disability and Rehabilitation · doi:10.1080/09638280500191753 · Cited by 182 · see citing works
Tan-Kristanto, S., & Kiropoulos, L. A. (2015) · Psychology, Health & Medicine · doi:10.1080/13548506.2014.999810 · Cited by 161 · see citing works
Nyenhuis, D. L., & Luchetta, T. (1998) · Journal of Personality Assessment · doi:10.1207/s15327752jpa7002_14 · Cited by 155 · see citing works
Temporal Lobe Involvement in Multiple Sclerosis Patients With Psychiatric Disorders
Honer, W. G., Hurwitz, T. A., Li, D. K. B., Palmer, M., & Paty, D. W. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520140053017 · Cited by 154 · see citing works
An examination of four models predicting fatigue in multiple sclerosis
STROBER, L., & ARNETT, P. (2005) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2005.04.002 · Cited by 151 · see citing works
Self-citationThe effects of anxiety on psychiatric morbidity in patients with multiple sclerosis
Feinstein, A., O'Connor, P., Gray, T., & Feinstein, K. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500504 · Cited by 147 · see citing works
Koelmel, E., Hughes, A. J., Alschuler, K. N., & Ehde, D. M. (2016) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2016.09.127 · Cited by 144 · see citing works
Psychiatric morbidity in multiple sclerosis: a clinical and MRI study
Ron, M. A., & Logsdail, S. (1989) · Psychological Medicine · doi:10.1017/s0033291700005602 · Cited by 136 · see citing works
Anxiety, depression, and comorbid anxiety and depression: risk factors and outcome over two years
Almeida, O. P., Draper, B., Pirkis, J., Snowdon, J. A., Lautenschlager, N. T., Byrne, G. J., Sim, M., Stocks, N., Kerse, N. M., Flicker, L. A., et al. (2012) · International Psychogeriatrics · doi:10.1017/s104161021200107x · Cited by 135 · see citing works
Treatment of depression for patients with multiple sclerosis in neurology clinics
Mohr, D. C., Hart, S. L., Fonareva, I., & Tasch, E. S. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1265oa · Cited by 126 · see citing works
Social support as a predictor of perceived health status in patients with multiple sclerosis
Krokavcova, M., van Dijk, J. P., Nagyová, I., Rosenberger, J., Gavelova, M., Middel, B., Gdovinová, Z., & Groothoff, J. W. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2008.03.019 · Cited by 120 · see citing works
Lesion pattern in patients with multiple sclerosis and depression
Berg, D., Supprian, T., Thomae, J., Warmuth‐Metz, M., Horowski, A., Zeiler, B., Magnus, T. U., Rieckmann, P., & Becker, G. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600304 · Cited by 113 · see citing works
A systematic review of anxiety amongst people with Multiple Sclerosis
Butler, E., Matcham, F., & Chalder, T. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.10.003 · Cited by 111 · see citing works
D, D. M. M., Fortney, J. C., Pyne, J. M., Edlund, M. J., & Wetherell, J. L. (2006) · Psychiatric Services · doi:10.1176/appi.ps.57.12.1731 · Cited by 110 · see citing works
A prospective study on the prognosis of multiple sclerosis
Amato, M. P., & Ponziani, G. (2000) · Neurological Sciences · doi:10.1007/s100720070021 · Cited by 108 · see citing works
Suicidal ideation in multiple sclerosis.
Turner, A., Williams, R. M., Bowen, J., Kivlahan, D., & Haselkorn, J. (2006) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2006.04.021 · Cited by 106 · see citing works
Unrecognised symptoms of depression in a community–based population with multiple sclerosis
McGuigan, C., & Hutchinson, M. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0963-0 · Cited by 102 · see citing works
Lester, K. W., Stepleman, L., & Hughes, M. (2007) · Journal of behavioral medicine · doi:10.1007/s10865-007-9095-6 · Cited by 94 · see citing works
Screening for Major Depression in the Early Stages of Multiple Sclerosis
Sullivan, M. J. L., Weinshenker, B. G., Mikail, S. F., & Bishop, S. R. (1995) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100039895 · Cited by 89 · see citing works
Cerebral Magnetic Resonance Imaging Findings in Multiple Sclerosis
Reischies, F. M. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520340068014 · Cited by 80 · see citing works
Depressive symptoms and MRI changes in multiple sclerosis
Zorzon, M., Zivadinov, R., Nasuelli, D., Ukmar, M., Bratina, A., Tommasi, M. A., Mucelli, R. P., Brnabic-Razmilic, O., Grop, A., Bonfigli, L., et al. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00442.x · Cited by 75 · see citing works
Counsell, A., Furtado, M., Iorio, C., Anand, L., Canzonieri, A., Fine, A., Fotinos, K., Epstein, I., & Katzman, M. A. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.046 · Cited by 73 · see citing works
The association of depression with disease course in multiple sclerosis
Zabad, R. K., Patten, S. B., & Metz, L. M. (2005) · Neurology · doi:10.1212/01.wnl.0000149760.64921.aa · Cited by 69 · see citing works
Pujol, J., Bello, J., Deus, J., Cardoner, N., Jl, M.-V., & Capdevila, A. (2000) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(00)00061-5 · Cited by 68 · see citing works
Psychological Predictors of Depression in Multiple Sclerosis
Shnek, Z. M., Foley, F. W., LaRocca, N. G., Smith, C. R., & Halper, J. (1995) · Neurorehabilitation and neural repair · doi:10.1177/154596839500900103 · Cited by 66 · see citing works
Strober, L. B., & Arnett, P. A. (2015) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2015.1063591 · Cited by 66 · see citing works
Self-citationDubayova, T., Krokavcova, M., Nagyova, I., Rosenberger, J., Gdovinova, Z., Middel, B., Groothoff, J. W., & van Dijk, J. P. (2013) · Quality of Life Research · doi:10.1007/s11136-012-0257-9 · Cited by 59 · see citing works
The co-occurrence of pain and depression in adults with multiple sclerosis
Alschuler, K. N., Ehde, D. M., & Jensen, M. P. (2013) · Rehabilitation Psychology · doi:10.1037/a0032008 · Cited by 56 · see citing works
For the CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease, Marrie, R. A., Walld, R., Bolton, J. M., Sareen, J., Walker, J. R., Patten, S. B., Singer, A. G., Lix, L. M., Hitchon, C. A., et al. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2958-1 · Cited by 55 · see citing works
Gill, S., Santo, J., Blair, M., & Morrow, S. A. (2019) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.18010011 · Cited by 46 · see citing works
Fernández-Jiménez, E., & Arnett, P. A. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514562439 · Cited by 45 · see citing works
Holland, D. P., Schlüter, D. K., Young, C. A., Mills, R. J., Rog, D. J., Ford, H. L., & Orchard, K. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.10.016 · Cited by 38 · see citing works
Strober, L. B., Becker, A., & Randolph, J. J. (2018) · Applied Neuropsychology Adult · doi:10.1080/23279095.2018.1458518 · Cited by 38 · see citing works
Self-citationDevelopment and Initial Analysis of Multiple Sclerosis Self-Management Scale
Bishop, M. L., & Frain, M. P. (2007) · International Journal of MS Care · doi:10.7224/1537-2073-9.2.35 · Cited by 36 · see citing works
Coping Strategies and Mood Profiles in Patients with Multiple Sclerosis
Milanlioglu, A., Özdemir, P. G., Cilingir, V., Gülec, T. Ç., Aydin, M. N., & Tombul, T. (2014) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20140089 · Cited by 33 · see citing works
Assessment Of Depression In Multiple Sclerosis: Development Of A “Trunk And Branch” Model
Strober, L. B., & Arnett, P. A. (2010) · The Clinical Neuropsychologist · doi:10.1080/13854046.2010.514863 · Cited by 25 · see citing works
Self-citation‘It’s the unknown’ – understanding anxiety: from the perspective of people with multiple sclerosis
Butler, E., Thomas, R., Carolan, A., Silber, E., & Chalder, T. (2018) · Psychology and Health · doi:10.1080/08870446.2018.1541989 · Cited by 25 · see citing works
Frühwald, S., Löffler‐Stastka, H., Eher, R., Saletu, B., & Baumhackl, U. (2001) · PubMed · Cited by 20 · see citing works
Anxiety is more important than depression in MS – Yes
Morrow, S. A. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517751652 · Cited by 17 · see citing works
Subjective well-being differs with age in multiple sclerosis: A brief report.
Stern, B. Z., Strober, L. B., DeLuca, J., & Goverover, Y. (2018) · Rehabilitation Psychology · doi:10.1037/rep0000220 · Cited by 14 · see citing works
Self-citationAnxiety is more important than depression in MS – No
Turner, A. P., & Alschuler, K. N. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517748477 · Cited by 6 · see citing works
Flagged first, then by citations
2 of the 64 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The relationship between purpose in life and depression and anxiety: A meta-analysis.
Boreham, I. D., & Schutte, N. (2023) · Journal of Clinical Psychology · doi:10.1002/jclp.23576 · Cited by 139 · see citing works
Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis
Margoni, M., Preziosa, P., Rocca, M. A., & Filippi, M. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02555-7 · Cited by 145 · see citing works
“Moreover, MS patients with anxiety disorders experience significantly more fatigue, pain and sleep problems, which worsen with the co-occurrence of depression [84].”
BackgroundSabour, S., Zhang, W., Xiao, X., Zhang, Y., Zheng, Y., Wen, J., Zhao, J., & Huang, M. (2023) · Frontiers in Digital Health · doi:10.3389/fdgth.2023.1133987 · Cited by 102 · see citing works
Valentine, T. R., Alschuler, K. N., Ehde, D. M., & Kratz, A. L. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585211023352 · Cited by 55 · see citing works
Kołtuniuk, A., Pawlak, B., Krówczyńska, D., & Chojdak-Łukasiewicz, J. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.1068421 · Cited by 49 · see citing works
“However, the hereby confirms a correlation between the level of education and the severity of depression symptoms—individuals with a university education experience fewer symptoms of depression (Winiecka et al., 2016; Hanna and Strober, 2020).”
BackgroundHajiluian, G., Karegar, S. J., Shidfar, F., Aryaeian, N., Salehi, M., Lotfi, T., Farhangnia, P., Heshmati, J., & Delbandi, A. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155094 · Cited by 40 · see citing works
Long, V. S., Chen, Z., Du, R., Chan, Y. H., Yew, Y. W., Oon, H. H. B., Thng, S. T. G., Lim, N. Q. B. I., Tan, C. L., Chandran, N. S., et al. (2023) · JAMA Dermatology · doi:10.1001/jamadermatol.2023.2008 · Cited by 38 · see citing works
Davis, B. E., Lakin, L., Binns, C. C., Currie, K. M., & Rensel, M. R. (2021) · Neurology and Therapy · doi:10.1007/s40120-021-00240-9 · Cited by 37 · see citing works
“By normalizing conversations around mental health and implementing appropriate management strategies, HCPs can empower people living with MS to navigate the stressors and uncertainties of living with MS while maintaining their QoL.”
BackgroundInfluentialDepression and anxiety in multiple sclerosis. Review of a fatal combination
Jellinger, K. A. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02792-0 · Cited by 41 · see citing works
“A comparison of persons with MS and healthy controls found that the fear of corona virus and sleep quality were not different, whereas the anxiety and depression levels were significantly higher, although the fear of virus did not have a significant effect on the QoL (Yeni et al. 2022).”
InfluentialZhang, X., Song, Y., Wei, Z., Chen, X., Zhuang, X., & Li, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1120541 · Cited by 37 · see citing works
Lee, B. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103421 · Cited by 31 · see citing works
Huang, Z., Zhang, L., Wang, J., Xu, L., Liu, Z., Wang, T., Guo, M., Xu, X., & Lu, H. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08621 · Cited by 31 · see citing works
“On the other hand, anxiety has been shown to be negatively related to subjective well-being, that is, the higher the level of anxiety, the lower the level of subjective well-being (Hanna and Strober, 2020).”
Vong, V., Simpson, S., Phaiju, S., Davenport, R. A., Neate, S. L., Pisano, M. I., & Reece, J. C. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104501 · Cited by 31 · see citing works
Menculini, G., Mancini, A., Gaetani, L., Bellingacci, L., Tortorella, A., Parnetti, L., & Filippo, M. D. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-329806 · Cited by 22 · see citing works
Management of multiple sclerosis in older adults: review of current evidence and future perspectives
DiMauro, K. A., Swetlik, C., & Cohen, J. A. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12384-3 · Cited by 27 · see citing works
“Anxiety tends to occur in younger patients and has been associated with shorter disease duration, though with notable overlap with depression [106].”
BackgroundCerea, S., Ghisi, M., Pitteri, M., Guandalini, M., Strober, L. B., Scozzari, S., Crescenzo, F., & Calabrese, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235607 · Cited by 24 · see citing works
Self-citationHomayuni, A., Abedini, S., Hosseini, Z., Etemadifar, M., & Ghanbarnejad, A. (2021) · BMC Neurology · doi:10.1186/s12883-021-02213-9 · Cited by 20 · see citing works
The emotional disorders associated with multiple sclerosis.
Raimo, S., Santangelo, G., & Trojano, L. (2021) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-822290-4.00009-8 · Cited by 19 · see citing works
Mikula, P., Timková, V., Fedičová, M., Szilasiová, J., & Nagyová, I. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103069 · Cited by 18 · see citing works
Alswat, A. M., Altirkistani, B. A., Alserihi, A. R., Baeshen, O. K., Alrushid, E. S., Alkhudair, J., Aldbas, A. A., Wadaan, O. M., Alsaleh, A., Malik, Y. M. A., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1195101 · Cited by 18 · see citing works
Stigma and health outcomes in multiple sclerosis: a systematic review
Powell, B., Mills, R. J., Tennant, A., Young, C. A., & Langdon, D. W. (2024) · BMC Neurology · doi:10.1186/s12883-024-03853-3 · Cited by 20 · see citing works
Sullivan, A. B., Davis, B. E., Kidd, J., & Chiong-Rivero, H. (2025) · Neurology and Therapy · doi:10.1007/s40120-025-00728-8 · Cited by 17 · see citing works
Saifan, A. R., AbuRuz, M. E., Assaf, E. A., Rayyan, A., Jaberi, M. A., & Masa’Deh, R. (2021) · Depression Research and Treatment · doi:10.1155/2021/8300497 · Cited by 17 · see citing works
Clinical correlates of state and trait anxiety in multiple sclerosis
Menculini, G., Gentili, L., Gaetani, L., Mancini, A., Sperandei, S., Sabatino, E. D., Chipi, E., Salvadori, N., Tortorella, A. A. V., Parnetti, L., et al. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104431 · Cited by 16 · see citing works
Dakanalis, A., Tryfonos, C., Pavlidou, E., Vadikolias, Κ., Papadopoulou, S. Κ., Alexatou, O., Vorvolakos, T., Chrysafi, M., Fotiou, D. F., Mentzelou, M., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14020199 · Cited by 15 · see citing works
Potentially modifiable associates of anxiety in people with multiple sclerosis: a systematic review
Fahy, A., & Maguire, R. (2022) · Disability and Rehabilitation · doi:10.1080/09638288.2021.2022776 · Cited by 15 · see citing works
Factors that influence quality of life in patients with multiple sclerosis in Saudi Arabia
Abdulla, F. A., Albagmi, F. M., & Al-Khamis, F. A. (2021) · Disability and Rehabilitation · doi:10.1080/09638288.2021.1919929 · Cited by 14 · see citing works
Eghbali, B. B., Saadat, S., Hasanzadeh, K., Pourramzani, A., Khatami, S., Saberi, A., & Jafroudi, M. (2022) · Postępy Psychiatrii i Neurologii · doi:10.5114/ppn.2022.117999 · Cited by 14 · see citing works
“0/) volved in the processing and perception of emotions [11] supports the notion that symptoms of anxiety and depression, as well as the decline in psychological well-being observed among PwMS, have a biological etiology [12].”
BackgroundMachine learning approaches to anxiety detection: trends, model evaluation, and future directions
Taskynbayeva, M., & Gutoreva, A. (2025) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2025.1630047 · Cited by 18 · see citing works
Buono, V. L., Bonanno, L., Corallo, F., Cardile, D., D’Aleo, G., Rifici, C., Sessa, E., Quartarone, A., & Cola, M. C. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103606 · Cited by 13 · see citing works
“MS affects, indeed, many spheres of functioning associated with physiological and psychological change that reduces physical function and leads to disability with a substantial impact on the sense of identity and redefinition of self-image [37].”
BackgroundFeng, G., Posa, S., Sureshkumar, A., Simpson, S., Bruno, T. R., Morrow, S. A., Donkers, S. J., Knox, K. B., Feinstein, A., Bayley, M. T., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-023-12116-z · Cited by 13 · see citing works
“For instance, symptoms of anxiety, depression, and fatigue are highly prevalent among PwMS [3–5]; with prevalence rates of 30.5% for depression and 22.1% for anxiety reported in a recent meta-analysis [6].”
InfluentialScandurra, C., Rosa, L., Carotenuto, A., Moccia, M., Arena, S., Ianniello, A., Nozzolillo, A., Turrini, M., Streito, L. M., Abbadessa, G., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062215 · Cited by 13 · see citing works
Rahimi, H., Pirmoradi, M., Lavasani, F. F., & Farahani, H. (2023) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_521_22 · Cited by 12 · see citing works
“This component is increasingly considered as an important indicator of the effectiveness of health interventions in the field of health policymaking.[13] In this regard, the results of previous studies have shown that patients with MS have significantly lower quality of life compared to healthy people in the community…”
ResultAutoimmune demyelination alters hypothalamic transcriptome and endocrine function
Carver, J. J., Lau, K. M., Puckett, A. E., & Didonna, A. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03006-2 · Cited by 13 · see citing works
“Consistently, MS patients are more likely to report depression, anxiety, and chronic fatigue at prevalence rates at least 2–3 times higher than the general population average [13–15] .”
BackgroundStoll, S. S., Costello, K., Newsome, S. D., Schmidt, H. K., Sullivan, A. B., & Hendin, B. A. (2024) · Neurology and Therapy · doi:10.1007/s40120-023-00573-7 · Cited by 12 · see citing works
“In a USA-based multicenter observational study in 183 patients with MS, 24% experienced depression and 22% experienced significant anxiety [62].”
BackgroundGiedraitienė, N., Gasciauskaite, G., & Kaubrys, G. (2022) · Scientific Reports · doi:10.1038/s41598-022-19748-7 · Cited by 12 · see citing works
Manche, S., & Probst, Y. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104958 · Cited by 11 · see citing works
Khushboo, Kumar, A., & Sharma, B. (2021) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557521666210415112601 · Cited by 11 · see citing works
Davenport, R. A., Krug, I., Rickerby, N. C., Dang, P. L., Forte, E., & Kiropoulos, L. A. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100832 · Cited by 10 · see citing works
Cárdenas‐Robledo, S., Otero‐Romero, S., Passarell‐Bacardit, M. A., Carbonell‐Mirabent, P., Sastre‐Garriga, J., Montalbán, X., & Tintoré, M. (2021) · European Journal of Neurology · doi:10.1111/ene.15030 · Cited by 10 · see citing works
Różycka, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258740 · Cited by 11 · see citing works
“This is also consistent with the research by Hanna and Strober [84], in which an interdependence was found between anxiety and depression was observed, particularly among those with shorter illness duration.”
ResultCoping with multiple sclerosis: reconciling significant aspects of health-related quality of life
Gil-González, I., Rodríguez, A. M., Conrad, R., & Pérez-San-Gregorio, M. Á. (2022) · Psychology Health & Medicine · doi:10.1080/13548506.2022.2077395 · Cited by 10 · see citing works
“In fact, social support has been related to improvements regarding fatigue (Mikula et al., 2020), pain (Alphonsus & D’Arcy, 2021), depression and anxiety (Hanna & Strober, 2020; Mikula et al., 2020; Ratajska et al., 2020), thereby also protecting employment (Iwanaga et al., 2018).”
BackgroundDeng, Q., Parker, E., Wu, C., Zhu, L., Liu, T. C., Duan, R., & Yang, L. (2024) · Aging and Disease · doi:10.14336/ad.2024.0239 · Cited by 10 · see citing works
“On the other side, persistent weariness represents a prevalent and incapacitating symptom in MS patients, particularly those with comorbid anxiety disorders and depression, who suffer from more pronounced and protracted chronic fatigue [316].”
Not for everyone: Factors influencing who receives psychotherapy in people with multiple sclerosis
Freedman, D., Oh, J., & Feinstein, A. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106245 · Cited by 9 · see citing works
Lucas, L., & Parker, J. C. (2022) · Archives of Physiotherapy · doi:10.1186/s40945-021-00124-z · Cited by 9 · see citing works
“However, despite this finding, anxiety is often overshadowed by depression, resulting in undertreatment and its presence being overlooked by many health professionals [7].”
BackgroundInfluentialGaballah, S. H., El-Deen, D. S., & Hebeshy, M. I. (2023) · Applied Nursing Research · doi:10.1016/j.apnr.2023.151719 · Cited by 8 · see citing works
Chmiel, J., Kurpas, D., & Stępień–Słodkowska, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020373 · Cited by 8 · see citing works
“For example, the severity of depression symptoms is correlated with education level; those who have completed college tend to have less depressive symptoms [110,111].”
Manocchio, N., Moriano, C., D’Amato, A., Bossa, M., Foti, C., & Nocentini, U. (2025) · NeuroSci · doi:10.3390/neurosci6030064 · Cited by 8 · see citing works
“Anxiety may have an even greater impact on psychological symptoms and QoL than depression alone, especially when both are present [53].”
Baik, J. S., Yang, J., Ko, S., Lee, S.-J., & Shin, Y. (2023) · Life · doi:10.3390/life13051172 · Cited by 8 · see citing works
Greene, N., Quéré, S., Bury, D. P., Mazerolle, F., M’Hari, M., Loubert, A., Regnault, A., & Higuchi, K. (2023) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-023-00594-8 · Cited by 8 · see citing works
“However, given the wide-ranging impact that MS has on patients’ well-being [46], providing meaningful change thresholds on the different subscales broadens the utility of the PRO instruments and allows meaningful improvements in these symptoms to be captured from the patient’s perspective.”
BackgroundSzczęśniak, M., Potemkowski, A., Brola, W., Kroplewski, Z., Szałachowski, R. R., Žák, M., Wilski, M., Sobolewski, P. K., Bartosik-Psujek, H., Kapica-Topczewska, K., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095426 · Cited by 10 · see citing works
“Individuals diagnosed with MS often face the unpredictability of their illness [6,14,15] and challenges related to psychological, social, and economic functioning [6,7].”
BackgroundUnderstanding the Effect of Multiple Sclerosis on General and Dimensions of Mental Health
Kang, W. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247483 · Cited by 7 · see citing works
“Second, neuroinflammation could explain the associations between MS and personality traits, with subclinical neuroinflammation predicting psychological change [38,39].”
BackgroundMcCormack, D., O’Keeffe, F. M., Seery, C., & Eccles, F. J. R. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106226 · Cited by 7 · see citing works
Curatoli, C., Marcassoli, A., Barbadoro, F., Fornari, A., Leonardi, M., Raggi, A., Schiavolin, S., Terragni, R., Antozzi, C. G., Brambilla, L., et al. (2025) · Behavioural Neurology · doi:10.1155/bn/2744955 · Cited by 7 · see citing works
Lal, A., Dhadwal, P., Gade, D., & Joy, J. (2024) · International Conference on Communication, Control and Intelligent Systems (CCIS) · doi:10.1109/ccis63231.2024.10932101 · Cited by 7 · see citing works
Aging and the neuropsychiatry of multiple sclerosis: a cross-sectional study
Freedman, D., Oh, J., Einstein, G., & Feinstein, A. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13116-x · Cited by 8 · see citing works
Lee, B., McDaniels, B. W., & Grenawalt, T. A. (2022) · Psychology Health & Medicine · doi:10.1080/13548506.2022.2072915 · Cited by 7 · see citing works
Thomas, G. A., Riegler, K. E., Bradson, M. L., O’Shea, D. U., & Arnett, P. A. (2022) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acac086 · Cited by 7 · see citing works
Hassan, S. S., Darwish, E. S., Ahmed, G. K., Azmy, S. R., & Haridy, N. A. (2023) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-023-00702-x · Cited by 7 · see citing works
“Furthermore, in the current study, MS patients with anxiety were more vulnerable to depression, consistent with previous findings [69], indicating considerable comorbidity.”
BackgroundResultBackwards walking speed reserve in persons with multiple sclerosis
Monaghan, P. G., VanNostrand, M., & Fritz, N. E. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105556 · Cited by 7 · see citing works
Fragkiadaki, E., Anagnostopoulos, F., & Triliva, S. (2023) · Counselling and Psychotherapy Research · doi:10.1002/capr.12615 · Cited by 7 · see citing works
Behavioral disorders in multiple sclerosis: a comprehensive review
Jellinger, K. (2024) · Journal of neural transmission · doi:10.1007/s00702-024-02816-9
“When evaluating the risk factors/contributors of anxiety (and depression), younger age and disease duration are consistent predictors (Hanna and Strober 2020), as is presence of exacerbation phase in MS (Uguz et al. 2008).”
Amaslidou, A., Ierodiakonou‐Benou, I., Bakirtzis, C., Nikolaidis, I., Tatsi, T., Grigoriadis, N., & Nimatoudis, I. (2023) · AIMS neuroscience · doi:10.3934/neuroscience.2023027 · Cited by 6 · see citing works
“The negative role of anxiety in maintaining good MHQoL was highlighted in our research and remains a common finding (STAI State scc: −0.423, p 0.001, ST AI Trait scc: −0.550, p 0.001) [21,22,27,94,105–110].”
BackgroundResultInfluentialAlmarzouki, A. F., Alluhaibi, W., Salman, B., Almuhaiyawi, M., Alreemi, M., & Alsahafi, M. (2024) · Medicine · doi:10.1097/md.0000000000038982 · Cited by 6 · see citing works
“[45] It has been suggested that the psychological burden of IBD, including increased risk of anxiety and depression, may contribute to impaired cognitive function.”
BackgroundUncinate Fasciculus Lesion Burden and Anxiety in Multiple Sclerosis
Baller, E. B., Luo, A. C., Schindler, M., Cooper, E. C., Pecsok, M. K., Cieslak, M., Martin, M., Bar-Or, A., Elahi, A., Perrone, C., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.4751 · Cited by 6 · see citing works
Tavakoli Saleh, S., MA in Family Counselling, D. O. P., Ebrahimi, M. E., & Assistant Professor, D. O. P. (2021) · Avicenna Journal of Clinical Medicine · doi:10.52547/ajcm.28.2.126 · Cited by 6 · see citing works
Zare, L., Nayeri, N. D., Bahramnezhad, F., & Rasti, A. (2024) · Health Expectations · doi:10.1111/hex.70044 · Cited by 5 · see citing works
“Despite the prevalent focus in numerous studies on the adversities of living with MS [24 – 27], some studies, including the present one, also spotlight positive outcomes.”
BackgroundSalmani, S., Mousavi, S. H., Navardi, S., Hosseinzadeh, F., & Pashaeypoor, S. (2022) · BMC Neurology · doi:10.1186/s12883-022-03019-z · Cited by 5 · see citing works
“The prevalence rates of psychological and neurological changes, depression, and anxiety are 40–65% [9], 30–40%, and 36% in MS [10], respectively.”
BackgroundReece, J. C., Neate, S. L., Davenport, R. A., Milanzi, E., Nag, N., Bevens, W., Yu, M., Jelinek, G. A., & Simpson, S. (2023) · Acta Neurologica Belgica · doi:10.1007/s13760-023-02390-z · Cited by 5 · see citing works
“Despite evidence of biological aetiologies for depression in plwMS [28], our results support the contribution of psychological causes of depression [29], in particular family/ relationship situations perceived to have a negative impact.”
ResultKhoshsirat, N. A., Mokaram, R., Mahmoodi, Z., Shahrestanaki, E., & Ghavidel, N. (2024) · Brain and Behavior · doi:10.1002/brb3.70031 · Cited by 5 · see citing works
“Depression and anxiety are associated with progression of disability in MS. Social support is a predictor of anxiety and depression (Hanna & Strober, 2020; Vorobeychik et al., 2020).”
BackgroundFernández-Jiménez, E., Panyavin, I. S., Pérez-San-Gregorio, M. Á., & Schultheis, M. T. (2021) · Psicothema · doi:10.7334/psicothema2020.151 · Cited by 5 · see citing works
“Consequently, affective disorders such as depression and anxiety are very frequent comorbid conditions among patients with MS (Hanna & Strober, 2020), and both impact the disease course predicting future relapses (Salter et al., 2020).”
BackgroundNeuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis
Jakimovski, D., Wicks, T. R., Bergsland, N., Dwyer, M. G., Weinstock‐Guttman, B., & Zivadinov, R. (2023) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s384038 · Cited by 5 · see citing works
“Additionally, living with a chronic disease such as MS is associated with higher incidence of psychosocial consequences like anxiety, lower life satisfaction, lower self-esteem and reoccurring feelings of guilt.(4)”
BackgroundTaul-Madsen, L., Hvid, L. G., Sellebjerg, F. T., Christensen, J. R., Ratzer, R. L., Sejbæk, T., Svendsen, K. B., Papp, V., Chow, H. H., Lundbye‐Jensen, J., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-085241 · Cited by 5 · see citing works
O'Keeffe, F., Cogley, C., McManus, C., Davenport, L., O'Connor, S., Tubridy, N., Gaughan, M., McGuigan, C., & Bramham, J. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105719 · Cited by 4 · see citing works
Karegar, S. J., Mirzaei, A., Hajiluian, G., Aryaeian, N., Shidfar, F., Arabgol, S., Khosravifar, S., Moradiani, M., Aghcheli, M., Kayyal, M., et al. (2025) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/20552173251331524 · Cited by 4 · see citing works
Body image, sexual dysfunction and psychological distress in people with multiple sclerosis
Breheny, E., O’Keeffe, F. M., & Cooney, S. M. (2025) · Disability and Rehabilitation · doi:10.1080/09638288.2025.2527959 · Cited by 4 · see citing works
“…[20]. additional psychological well-being variables that have consistently been shown to be more prevalent in people with Ms, including depression [21] and anxiety [22], will also be explored in the current study to better understand the role they play in the sexual and bodily experience. this…”
Pérez, E. R. P., López, M. L. B., Fernández, E. G., Arnés, M. D. R. M., Vázquez, M. F., Hernández, M., & García, E. G. (2025) · Neurology International · doi:10.3390/neurolint17120195 · Cited by 4 · see citing works
“Emerging evidence suggests that early interventions targeting emotional and social dimensions can significantly improve long-term outcomes in RRMS patients [12–14].”
Betti, M., Masciulli, C., Addazio, I., Ballerini, C., Bonacchi, R., Caporali, A., Chiappetta, F., Meo, E. D., Fabbiani, C., Gerli, F., et al. (2026) · Neurological Sciences · doi:10.1007/s10072-026-08988-4 · Cited by 4 · see citing works
Vicente-Escudero, J. L. (2025) · Journal of Technology in Behavioral Science · doi:10.1007/s41347-025-00488-0 · Cited by 4 · see citing works
Knowles, L. M., Tingey, J. L., Newman, A. K., von Geldern, G., & Alschuler, K. N. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103918 · Cited by 4 · see citing works
Polick, C. S., Ploutz-Snyder, R. J., Braley, T. J., Connell, C. M., & Stoddard, S. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292233 · Cited by 4 · see citing works
The experience of stigma and concealment in multiple sclerosis.
Maguire, R., Ahern, A., Shrivastava, S., & Maguire, P. (2024) · Stigma and Health · doi:10.1037/sah0000599 · Cited by 4 · see citing works
Kiropoulos, L. A., Krug, I., & Dang, P. L. (2025) · Nutrients · doi:10.3390/nu17101609 · Cited by 4 · see citing works
“…this comorbid presentation are crucial, as the combination of DE [84], body dissatisfaction [79], low self-esteem [23], and affective symptoms [85] may compound distress and interfere with disease management and quality of life in those affected by MS. Multimodal psychological approaches that…”
COMORBID PSYCHIATRIC DISORDERS IN SOME COMMON NEUROLOGICAL DISEASES
Görgülü, Ü., Gürhan, N., AKMAN, Y. Y., Polat, Ü., ALTAY, K., Özen, Ş., Çoşar, B., & Kolcu, G. (2022) · SDÜ Tıp Fakültesi Dergisi · doi:10.17343/sdutfd.1048635 · Cited by 4 · see citing works
Psychiatric-Like Impairments in Mouse Models of Spinocerebellar Ataxias
Tichánek, F. (2022) · The Cerebellum · doi:10.1007/s12311-022-01367-7 · Cited by 4 · see citing works
“1 3 even higher burden for patients with other motor neurological diseases, such as multiple sclerosis [46].”
BackgroundCerebrospinal fluid interferon-γ and development of depression in multiple sclerosis
Menculini, G., Sperandei, S., Gaetani, L., Mancini, A., Cinesi, G., Sabatino, E. D., Bellingacci, L., Canonichesi, J., Guerrera, G., Battistini, L., et al. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106309 · Cited by 3 · see citing works
Trauma Burden Affected People with Multiple Sclerosis During SARS-CoV-2 Pandemic
Heidler, F., Hecker, M., Frahm, N., Baldt, J., Streckenbach, B., Meißner, J., Burian, K., Langhorst, S. E., Mashhadiakbar, P., Richter, J., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082665 · Cited by 3 · see citing works
“Furthermore, feelings of helplessness and dependence on others may contribute to a higher prevalence of depressive disorders [111].”
Neuroanatomical Correlates of Depressive Symptoms in Early Multiple Sclerosis
Silva, J. D. S., Rosa, F. L., Dereskewicz, E., Levy, S. A., Graney, R., Garcia, N., Galasso, J., Sumowski, J. F., & Beck, E. S. (2026) · Neurology Open Access · doi:10.1212/wn9.0000000000000050 · Cited by 3 · see citing works
Hoepner, R., Rodgers, S., Stegmayer, K., Steinemann, N., Haag, C., Calabrese, P., Manjaly, Z., Salmen, A., Kesselring, J., Zecca, C., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22445-0 · Cited by 3 · see citing works
Göçmen, A., & Ethemoğlu, Ö. (2023) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2023.107888 · Cited by 4 · see citing works
Giossi, R., Mercenari, M., Filippi, M., Zanetta, C., Antozzi, C. G., Brambilla, L., Confalonieri, P. A., Crisafulli, S. G., Roldán, E. T., Annovazzi, P. O. L., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12472-4 · Cited by 3 · see citing works
Connolly, L. J., Chatfield, S., Freeman, J. A., Salter, A. R., Amato, M. P., Brichetto, G., Chataway, J., Chiaravalloti, N. D., Cutter, G., DeLuca, J., et al. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105798 · Cited by 3 · see citing works
“…correlations between fatigue and measures of depressive symptoms and anxiety have been found by some (Sparasci et al., 2022; Tarasiuk et al., 2021), with others identifying moderate statistically significant correlations with depressive symptoms (AlSaeed et al., 2022; Hanna and Strober, 2020).”
Chmiel, J., & Stępień–Słodkowska, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247793 · Cited by 3 · see citing works
“Depression affects approximately 30.5% of MS patients, while anxiety impacts around 22.1% [1,2].”
InfluentialFakorede, S., Peters, J., Murphy, T., Troung, E., & Abou, L. (2025) · Physiotherapy Theory and Practice · doi:10.1080/09593985.2025.2518261 · Cited by 3 · see citing works
“These mental health conditions arise from a combination of psychosocial and biological factors, including inadequate coping mechanisms, insufficient social support, and MS-related changes in brain structure, immune function, and inflammatory pathways (Hanna and Strober, 2020; Mustač et al, 2021).”
Phillips, B., Morrow, S. A., Singh, H., Oh, J., Kolind, S., Lynd, L. D., Prat, A., Tam, R. C., Traboulsee, A. L., & Patten, S. B. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106761 · Cited by 3 · see citing works
The effect on the anxiety level of the social support given to multiple sclerosis patients
Yılmaz, T. A., & Özdelikara, A. (2021) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12807 · Cited by 3 · see citing works
Quality of Life and Its Predictors in Patients with Multiple Sclerosis
Sotoudeh, S., Maroufizadeh, S., Balasi, L. R., Esfandiari, A., Nouri, A., & Bakhtiari, F. (2023) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc-138840 · Cited by 3 · see citing works
Roman, M. S., González, F., Bardoneschi, L., Fernández, M. H., Eizaguirre, M., Cáceres, F., Benedict, R. H. B., Rivera, V. M., & Vanotti, S. (2024) · Sclerosis · doi:10.3390/sclerosis2010005 · Cited by 3 · see citing works
“…was included, which underlines the importance of studying this variable in PwMS and incorporating it into models when examining both employment and other self-reported questionnaires, in particular perceived social support, as they may be influenced by the presence of depressive symptoms [50].”
BackgroundResultThe Path from Personality to Anxiety and Depression Is Mediated by Cognition in Multiple Sclerosis
Schenk, A., Popa, C. O., Cojocaru, C. M., Marian, Ș., Maier, S., & Bălașa, R. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14070682 · Cited by 3 · see citing works
Özbek, M., Arıkanoğlu, A., & Aluçlu, M. U. (2025) · Medicina · doi:10.3390/medicina61081409 · Cited by 2 · see citing works
“The lifetime prevalence of depression in MS patients has been estimated at 30 to 40 percent [29,30] while anxiety prevalence ranges from 35 to 65 percent [31].”
- Authors
- Hanna, M., & Strober, L. B.
- Affiliations
- Montclair State University (US)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Strober, Lauren Beth
- ORCID
- Strober, Lauren Beth
- Venue
- Multiple Sclerosis and Related Disorders
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 44
- Pages
- 102261
- ISSN
- 2211-0348 (ISSN-L)
- PMC
- PMC7719086
- OpenAlex
- W3033947017
- Cited by
- 202
- References
- 64
- Citations by year
- 2026: 38 · 2025: 35 · 2024: 52 · 2023: 33 · 2022: 21 · 2021: 23
- FWCI
- 12.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Multiple Sclerosis and Related Disorders (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- multiple sclerosis, anxiety, depression, psychological well-being, quality of life, social support, substance use, disease duration, risk factors, symptom severity, early detection
- MeSH terms
- Anxiety, Anxiety Disorders, Depression, Humans, Multiple Sclerosis, Quality of Life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
